Was to be expected J8 once the buy volume dried up in the market . I must admit did not think this low . Brokers and the real money makers know how to squeeze the best price out of the market , they have done very well at churning a buck for a month , they made plenty rest assured . So did I as a matter of fact . As usual the market has it wrong again , it will get back to a very handsome price of of $200 to $250 market cap in very near future , one thing I have learned in last 4 weeks there are more traders in market than investors .There will be deals imminent my friend or the whole damn lot , a pharma will not miss this opportunity to knock out their competitors here . There is still more to come in the journal . It would not surprise me to see that word eradication even though you hate it . $10 million per compound is not a ridiculous ask .
28th Aug 2017 : Gilead to buy Kite Pharma in $11.9 billion deal
22nd Nov 2011 : Gilead bets $11 billion on hepatitis in Pharmasset deal
22nd Jan 2018 : With $9 Billion Juno Deal, Celgene Doubles Down on Cancer
22nd Jan 2018 : Sanofi Delivers $11.6 Billion Deal After Striking Out Twice
20th Aug 2018 : China Biologic gets $3.9 billion offer from former CEO-led consortium
10th July 2018 : Takeda Clears Hurdle for $62 Billion Shire Deal
$10 Billion Deal, page-14
-
- There are more pages in this discussion • 13,249 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
